検索
Cyclerion Therapeutics Inc
CYCNウォッチリストに追加
3.370USD
-0.020-0.59%
取引時間 （ET）15分遅れの株価
12.88M時価総額
損失額直近12ヶ月PER
詳細情報 Cyclerion Therapeutics Inc 企業名
Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering therapies for central nervous system (CNS) diseases. The Company is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. It is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The Company has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.
Cyclerion Therapeutics Incの企業情報
企業コードCYCN
会社名Cyclerion Therapeutics Inc
上場日Mar 18, 2019
最高経営責任者「CEO」Graul (Regina M)
従業員数1
証券種類Ordinary Share
決算期末Mar 18
本社所在地301 Binney Street
都市CAMBRIDGE
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号02142
電話番号16176217722
ウェブサイトhttps://www.cyclerion.com/
企業コードCYCN
上場日Mar 18, 2019
最高経営責任者「CEO」Graul (Regina M)
Cyclerion Therapeutics Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
559.20K
--
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
--
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Rhonda M. Chicko
Ms. Rhonda M. Chicko
Chief Financial Officer
Chief Financial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
559.20K
--
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
--
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
よくある質問
Cyclerion Therapeutics Incの上位5名の株主は誰ですか？
Cyclerion Therapeutics Incの上位5名の株主は以下のとおりです。Dr. Peter M. Hecht, Ph.D.
Cyclerion Therapeutics Inc（CYCN）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Cyclerion Therapeutics Incの株式を保有している機関は37社あり、保有株式の総市場価値は約318.08Kで、全体の7.35%を占めています。2025Q4と比較して、機関の持ち株は-667233.00増加しています。